MARKET

ELDN

ELDN

Eledon Pharmaceuticals Inc
NASDAQ
3.220
+0.120
+3.87%
After Hours: 3.240 +0.02 +0.62% 19:21 04/13 EDT
OPEN
3.120
PREV CLOSE
3.100
HIGH
3.240
LOW
3.100
VOLUME
1.60M
TURNOVER
--
52 WEEK HIGH
4.600
52 WEEK LOW
1.350
MARKET CAP
244.24M
P/E (TTM)
-5.7768
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELDN last week (0406-0410)?
Weekly Report · 17h ago
Weekly Report: what happened at ELDN last week (0330-0403)?
Weekly Report · 04/06 10:31
Weekly Report: what happened at ELDN last week (0323-0327)?
Weekly Report · 03/30 10:31
Analysts’ Top Healthcare Picks: Madrigal Pharmaceuticals (MDGL), IDEAYA Biosciences (IDYA)
TipRanks · 03/23 13:30
Weekly Report: what happened at ELDN last week (0316-0320)?
Weekly Report · 03/23 10:28
Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Hims & Hers Health (HIMS) and Solid Biosciences (SLDB)
TipRanks · 03/20 12:20
Analysts Are Bullish on Top Healthcare Stocks: Humacyte (HUMA), Eledon Pharmaceuticals (ELDN)
TipRanks · 03/20 11:40
Eledon Pharma FY25 Net Loss Widens; Tegoprubart Phase 3 Development On Track In Kidney Transplant
NASDAQ · 03/20 09:40
More
About ELDN
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target within the costimulatory CD40/CD40L cellular pathway. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. Tegoprubart is engineered to potentially both improve safety and provides pharmacokinetic, pharmacodynamic, and dosing advantages. CD40L is primarily expressed on activated CD4+ T cells, platelets, and endothelial cells while the CD40 receptor is constitutively expressed on antigen-presenting cells, such as macrophages and dendritic cells, as well as B cells.

Webull offers Eledon Pharmaceuticals Inc stock information, including NASDAQ: ELDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELDN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELDN stock methods without spending real money on the virtual paper trading platform.